This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, Institut Pasteur Du Cambodge. Active years: 2024.
Company Filing History:
1 out of 5,383 
1 out of 897 
1 out of 5 Years Active: 2024
Title: Eric Legrand: Innovator in Malaria Detection
Introduction
Eric Legrand is a notable inventor based in Le Blanc-Mesnil, France. He has made significant contributions to the field of malaria detection, particularly in addressing piperaquine-resistant strains of Plasmodium falciparum. His innovative methods and reagents have the potential to improve patient outcomes in malaria treatment.
Latest Patents
Eric Legrand holds a patent for "Methods and reagents for detecting piperaquine-resistant Plasmodium falciparum malaria." This patent outlines a method for genotyping that includes providing a sample containing the pathogen and detecting the presence of an increased copy number of the genomic plasmepsin2-3 cluster. Additionally, the patent describes a method for detecting infection in a patient by analyzing a blood sample for the same genomic markers. The patent also includes kits for genotyping and methods for treating the infection.
Career Highlights
Throughout his career, Eric has worked with prestigious institutions such as Institut Pasteur and Institut Pasteur du Cambodge. His work has focused on advancing the understanding and treatment of malaria, particularly in regions where drug resistance is a growing concern.
Collaborations
Eric has collaborated with esteemed colleagues in his field, including Didier Menard and Frédéric Ariey. These partnerships have contributed to the development of innovative solutions for malaria detection and treatment.
Conclusion
Eric Legrand's contributions to malaria research and detection highlight the importance of innovation in addressing global health challenges. His work continues to pave the way for advancements in the fight against malaria.